Researchers Improve Screening For Attention Deficit-Hyperactivity Disorder (ADHD) Among Substance Users
Main Category: ADHDAlso Included In: Alcohol / Addiction / Illegal Drugs
Article Date: 27 Jul 2006 - 7:00 PDT
| Patient / Public: | ![]() |
4.14 (7 votes) |
| Healthcare Prof: | ![]() |
3.5 (14 votes) |
Attention Deficit-Hyperactivity Disorder (ADHD) is a major learning disability among both children and adults. ADHD is especially common among drug users and alcoholics and increases the severity of their addiction problems. ADHD is treatable, but diagnosing it among adult substance users has been difficult and expensive. Charles Cleland and his colleagues at National Development and Research Institutes in New York City found that a screening test originally developed for the general population the Conners Adult ADHD Rating Scale (CAARS) - also works well to identify ADHD symptoms among substance users. The CAARS is an effective, simple and inexpensive way to screen adult substance users for ADHD, so that they can be referred for confirmatory diagnosis and possible ADHD treatment.
Stephen Magura, the Principal Investigator of the study, remarks: Although more research is needed, our study shows that better screening of substance users for ADHD is possible, with the payoff that ADHD will be treated and recovery from addiction will be facilitated.
###
Cleland, Charles; Magura, Stephen; Foote, Jeffrey; Rosenblum, Andrew; Kosanke, Nicole. Factor structure of the Conners Adult ADHD Rating Scale (CAARS) for substance users. Addictive Behaviors. 2006 Jul;31(7):1277-82.
This study was supported by Grant No. RO1 DA12209 from the National Institute on Drug Abuse, S. Magura, Principal Investigator.
Contact: Betty Wagoner
National Development & Research Institutes
Visit our adhd section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/48063.php>
APA
http://www.medicalnewstoday.com/releases/48063.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





